Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Nearly a third of patients with high-grade serous ovarian cancer (HGSC) do not respond to initial therapy and have an overall poor prognosis. However, there are no validated tools that accurately predict which patients will not respond. Our objective is to create and validate accurate models of pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez Bosquet, Jesus, Devor, Eric J., Newtson, Andreea M., Smith, Brian J., Bender, David P., Goodheart, Michael J., McDonald, Megan E., Braun, Terry A., Thiel, Kristina W., Leslie, Kimberly K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971042/
https://www.ncbi.nlm.nih.gov/pubmed/33727600
http://dx.doi.org/10.1038/s41598-021-85256-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971042/
https://www.ncbi.nlm.nih.gov/pubmed/33727600
http://dx.doi.org/10.1038/s41598-021-85256-9

Ejemplares similares